These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Longitudinal ambulatory measurements of gait abnormality in dystrophin-deficient dogs. Barthélémy I, Barrey E, Aguilar P, Uriarte A, Le Chevoir M, Thibaud JL, Voit T, Blot S, Hogrel JY. BMC Musculoskelet Disord; 2011 Apr 13; 12():75. PubMed ID: 21489295 [Abstract] [Full Text] [Related]
28. Physical therapy assessment tools to evaluate disease progression and phenotype variability in Golden Retriever muscular dystrophy. Gaiad TP, Silva MB, Silva GC, Caromano FA, Miglino MA, Ambrósio CE. Res Vet Sci; 2011 Oct 13; 91(2):188-93. PubMed ID: 21315399 [Abstract] [Full Text] [Related]
29. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy. Vieira NM, Spinazzola JM, Alexander MS, Moreira YB, Kawahara G, Gibbs DE, Mead LC, Verjovski-Almeida S, Zatz M, Kunkel LM. Proc Natl Acad Sci U S A; 2017 Jun 06; 114(23):6080-6085. PubMed ID: 28533404 [Abstract] [Full Text] [Related]
40. Anatomical and mesoscopic characterization of the dystrophic diaphragm: An in vivo nuclear magnetic resonance imaging study in the Golden retriever muscular dystrophy dog. Thibaud JL, Matot B, Barthélémy I, Fromes Y, Blot S, Carlier PG. Neuromuscul Disord; 2017 Apr 06; 27(4):315-325. PubMed ID: 28258941 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]